REDEXIS ULTRA 1cc x1 PF Syringe
Hover over image to zoom
|
Sale Price: $269.00
Compared at: $330.00
You Save: $61.00
Product ID : redexis_ultra
Manufacturer: PROLLENIUM MEDICAL TECHNOLOGY
Purchase |
Description
REDEXIS ULTRA 1cc x1 PF Syringe
ReDexis® Ultra is a fully absorbable, high viscosity dermal filler for subcutaneous injection and is designed for creating and shaping facial contours. This non animal based, cross-linked HA gel utilizes the unique properties of dextranomer beads for collagen production. Its long lasting results are ideal for creating or restoring lost volume in areas such as the cheeks and the chin. Unlike other subcutaneous fillers currently on the market ReDexis® Ultra is easy to inject using only a 27G needle. An increased amount of dextranomer beads (50mg/ml) ensures maximum collagen production at the injection site for enduring results of up to 24 months
The key ingredient in ReDexis® - positively charged Dextranomer beads – is made of biocompatible cross linked glucose molecules. These beads attract negatively charged GAG and elastin (soft tissue) to the injection site to help form new collagen. They then begin to bind together, forming a scaffold of new collagen. This new collagen will stay at the injection site, providing natural augmentation long after the HA has been broken down and absorbed. The end result is increased volume to the injection site and a longer lasting and more natural look than traditional fillers.
ADVANTAGES
The Revanesse® line of fillers employs our Thixofix™ Technology - one of the most advanced methods of cross-linking available- thereby ensuring long lasting results. This patented process also ensures that the products remain easy to inject while not sacrificing viscosity. Additionally, Revanesse® fillers exclusively use HA with a high molecular weight to achieve maximum durability and longevity. In ReDexis® the use of dextranomer beads further enhances the longevity of the product. Overall, this innovative engineering makes the Revanesse® product line unique and exceptionally durable.
Thixofix Technology
Because there are many HA based fillers on the market, one may ask, "What makes the Revanesse® product line different?" The answer lies in our unique formula and patented Thixotropic cross-linking technology, which allows a highly viscous gel to be injected easily through a fine gauge needle without causing degradation to the modified HA particles while returning to its viscous state providing a soft smooth feel to the skin once it is injected.
Prollenium's® precisely crafted cross-linking process is designed to maximize the effectiveness of the cross-linked HA chains present in the gel. Links between different HA polymer chains are promoted, while ineffective 'dangling' links and less effective links between portions of the same chain are minimized. This leads to a gel, which derives maximum benefit in terms of mechanical properties and durability, with a minimum amount of BDDE – thus leading to fewer incidences of post injection complications such as swelling.
The osmolality and pH of the gel is balanced to be compatible with the fluid in the skin, neither drawing in or releasing water. This minimizes problems of overfilling or the need for volume correction. As the filler is slowly degraded over time the cross-linked network is loosened and this allows for slow expansion of the gel particles that partly offsets the natural loss in dermal filler volume, maintaining the level of correction.
Optimizing all these properties provides for a dermal filler with superior performance and patient satisfaction.
MONOPHASIC:
HA dermal fillers typically fall into one of two categories: biphasic or monophasic. Biphasic HA products consist of particles of stabilized HA gel suspended in a non-stabilized HA fluid. In contrast, monophasic HA products, such as Revanesse®, are made entirely of stabilized, non-particle, HA gel. The benefit of this approach is two fold.
First, the body's breakdown of biphasic HA differs from that of monophasic HA. Biphasic HA experiences a rapid initial degradation of the non-stabilized HA carrier fluid and a slower degradation of the stabilized HA gel; to combat this effect the physician will over-correct to compensate for the initial rapid degradation. This can lead to less than satisfactory results.
In contrast, monophasic HA degrades in a simple, consistent manner, allowing the physician to correct to the desired look thereby taking the guess work out of the final outcome. Second, in monophasic fillers, the entire volume of the syringe is filled with fine, soft gel particles packed together. This uniform composition leads to the desirable qualities of smoothness, uniformity, and accurate filling
EASE OF USE
The greatest care has been taken to ensure that the Revanesse® line of fillers is easy to inject. We have designed our syringes to include extra wide finger flanges and broadened pistons that provide much greater ease of use. This new design allows the physician a much higher degree of flexibility when injecting. The strong shear-thinning behavior of our HA formulation enables even the highly viscous Revanesse® Ultra to be easily injected with fine gauge needles without compromising the integrity of the gel.
Products You May Like
|
|
|
|
|
|
Comment on Facebook